3177 results for «370»

Filter By

3177 results

Where will the future of Robotics in Interventional Cardiology take us?

15 May 2023 – From PCR Innovators day 2023

Innovations in Mitral and Tricuspid Valves Disease interventions

15 May 2023 – From PCR Innovators Day 2023

A word from our sponsor

15 May 2023 – From PCR Innovators Day 2023

Innovations in Heart Failure: Pumps, Remodeling and Monitoring

15 May 2023 – From PCR Innovators Day 2023

How will "Big Data" and artificial intelligence change the practice in Interventional Cardiology?

15 May 2023 – From PCR Innovators Day 2023

Interventions on Pulmonary Embolism: The Next Big Thing?

15 May 2023 – From PCR Innovators Day 2023

What else will become the "Next Big Thing" in Coronary Artery Disease, Peripheral Vascular, treatment of Hypertension or Cardiovascular Imaging for the Interventional Cardiologist?

15 May 2023 – From PCR Innovators Day 2023

Feedback from Innovator's Exchange Hub

15 May 2023 – From PCR Innovators Day 2023

TAVI

18 Feb 2023 – From PCR Tokyo Valves 2023

Discover a selection of cases exploring TAVI at PCR Tokyo Valves 2023 in this session: long-term survival assessment after TAVI, cerebral embolic protection devices for stroke prevention, ultrasound-guided vs. conventional MANTA vascular closure devices, and more!

Tricuspid valve interventions - All you need to know

18 Feb 2023 – From PCR Tokyo Valves 2023

Gain comprehensive insights into tricuspid valve interventions in this session. Understand patient selection, transcatheter solutions for tricuspid regurgitation, effective procedural imaging, and explore recorded cases of transcatheter tricuspid valve interventions, including replacement and repair options.

Complication and bailout of mitral valve intervention

18 Feb 2023 – From PCR Tokyo Valves 2023

Experience the high-stakes world of bailouts of mitral valve intervention in this session: witness the intricate management of unexpected final arm angle during MitraClip procedure, delve into the challenges posed by an obstructive valve thrombosis of a bioprosthetic mitral valve, and uncover the complexities of takotsubo...

Management of mitral regurgitation patients undergoing TMVI screening

13 Jan 2022

This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.

Management of mitral regurgitation patients undergoing TMVI screening

PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis

07 Nov 2021

Professor David J. Cohen presented the results of the economic outcomes of the PARTNER 3 trial on Friday, 5 November, in the Late-Breaking Trial session of the Transcatheter Cardiovascular Therapeutics Congress 2021. Giuseppe Biondi-Zoccai provides his analysis of this study.

Giuseppe Biondi Zoccai

Author

Giuseppe Biondi-Zoccai
PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis

RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure

01 Sep 2024

Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.

The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...

Nicola Ryan

Author

Nicola Ryan
RESHAPE-HF2

The 2023 ESH Hypertension Guidelines revisit the role of renal denervation

05 Sep 2023

The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...

Lucas Lauder

Author

Lucas Lauder

Author

Felix Mahfoud
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation

3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications

22 Mar 2022

Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.

Author

Ali Nazmi Calik
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications

Transfemoral TAVI in the horizontal aorta

12 May 2020

Real-world case report illustrating the benefits of the Portico with FlexNav TAVI system.

Transfemoral TAVI in the horizontal aorta
Didn’t find what you were looking for?